Cargando…
Mesalazine-induced myopericarditis: a case series
BACKGROUND: Inflammatory bowel diseases (IBD) are characterized by chronic inflammation of the gastrointestinal tract but can have multiorgan involvement. Mesalazine (5-ASA) is a key therapeutic agent in IBD. Mesalazine has rare but potentially life-threatening side effects such as cardiac injury. C...
Autores principales: | Andrei, Valentina, D’Ettore, Nicoletta, Scheggi, Valentina, di Mario, Carlo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504860/ https://www.ncbi.nlm.nih.gov/pubmed/37719002 http://dx.doi.org/10.1093/ehjcr/ytad424 |
Ejemplares similares
-
Mesalazine-induced myopericarditis: a case report
por: Shergill, Simran
Publicado: (2020) -
Mesalazine-induced myopericarditis in a patient with ulcerative colitis
por: Asadi, Jalal, et al.
Publicado: (2017) -
Cerebral lesions in hematological malignancies: a case report
por: D’Ettore, Nicoletta, et al.
Publicado: (2021) -
Recurrent Mesalazine-Induced Myopericarditis in a Patient with Ulcerative Colitis
por: Park, Eun Hye, et al.
Publicado: (2012) -
Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
por: Sorleto, Michele, et al.
Publicado: (2015)